Alivus Life Sciences discloses two upcoming investor/analyst meetings scheduled for May 25 and 27, 2026.
Meetings include an in-person group conference with Ambit India and a one-on-one with Abakkus Asset Managers in Mumbai.
Disclosure is made pursuant to SEBI LODR Regulations, specifically Regulation 30 and Schedule III.
The company notes the schedule is subject to change due to exigencies from any involved party.